Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule;Valor do FDG[18F]-PET/TC como preditor de câncer em nódulo pulmonar solitário

Jornal Brasileiro de Pneumologia

Volumn 34, Issue 7, 2008, Pages 473-480

  Martins, Rafael De Castro ^a,d   De Almeida, Sérgio Altino ^b   Siciliano, Antônio Alexandre De Oliveira ^b   Landesmann, Maria Carolina Pinheiro Pessoa ^b   Da Silva, Fabrício Braga ^b   Franco, Carlos Alberto De Barros ^a   Da Fonseca, Lea Mirian Barbosa ^c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL SAMARITANO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d Hospital Samaritano ^*  (Brazil)

Author keywords

Coin lesion, pulmonary; Lung neoplasms; Positron emission tomography

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; AGE; AGE DISTRIBUTION; AGED; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; LUNG NODULE; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; ROC CURVE; SCINTISCANNING; SEX DIFFERENCE; SEX RATIO; SMOKING; STATISTICAL MODEL;

ADENOCARCINOMA; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; ROC CURVE; SEX DISTRIBUTION; SEX FACTORS; SMOKING; SOLITARY PULMONARY NODULE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 49449117795     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/S1806-37132008000700007     Document Type: Article

References (25)

1. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and the European Respiratory Society. Am J Respir Crit Care Med. 1997;156(1):320-32.
2. Tan BB, Flaherty KR, Kazerooni EA, Iannettoni MD; American College of Chest Physicians. The solitary pulmonary nodule. Chest. 2003;123(1 Suppl):89S-96S.
3. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003;348(25):2535-42.
4. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003;139(11):879-92.
5. Mavi A, Lakhani P, Zhuang H, Gupta NC, Alavi A. Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. Radiol Clin North Am. 2005;43(1):1-21, ix.
6. Rohren EM, Lowe VJ. Update in PET imaging of nonsmall cell lung cancer. Semin Nucl Med. 2004;34(2):134-53.
7. Hara T, Kosaka N, Suzuki T, Kudo K, Niino H. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. Chest. 2003;124(3):893-901.
8. Zhuang H, Yu JQ, Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am. 2005;43(1):121-34.
9. El-Haddad G, Alavi A, Mavi A, Bural G, Zhuang H. Normal variants in [18F]-fluorodeoxyglucose PET imaging. Radiol Clin North Am. 2004;42(6):1063-81, viii.
10. Bombarda S, Júnior JS, Filho MT. Estudo do metabolismo da glicose na tuberculose pulmonar ativa utilizando a tomografia por emissão de pósitrons (18F-FDG PET). J Pneumol. 2002;28(5):270-6.
11. Ministério da Saúde. Fundação Nacional de Saúde. Controle da Tuberculose: Uma Proposta de Integração Ensino-Serviço. 5th ed. Rio de Janeiro: FUNASA/CRPHF/SBPT; 2002. 237p.
12. Martins EM, Marchiori E, Damato SD, Pozes AS, Silva AC, Dalston M. Histoplasmose Pulmonar Aguda: Relato de uma Microepidemia. Radiol Bras 2003;36(3):147-51.
13. Rivera MP, Stover DE. Gender and lung cancer. Clin Chest Med. 2004;25(2):391-400.
14. Gilman MD, Fischman AJ, Krishnasetty V, Halpern EF, Aquino SL. Optimal CT breathing protocol for combined thoracic PET/CT. AJR Am J Roentgenol. 2006;187(5):1357-60.
15. Kinahan PE, Hasegawa BH, Beyer T. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med. 2003;33(3):166-79.
16. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13(4):601-9.
17. Ginsberg MS, Grewal RK, Heelan RT. Lung cancer. Radiol Clin North Am. 2007;45(1):21-43.
18. Fischer BM, Mortensen J, Højgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol. 2001;2(11):659-66.
19. Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007;48(2):214-20.
20. Yi CA, Lee KS, Kim BT, Choi JY, Kwon OJ, Kim H, et al. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med. 2006;47(3):443-50.
21. van Rens MT, de la Rivière AB, Elbers HR, van Den Bosch JM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest. 2000;117(2):374-9.
22. Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001;345(3):181-8.
23. Sachs S, Fiore JJ. An overview of lung cancer. Respir Care Clin N Am. 2003;9(1):1-25.
24. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest. 2005;128(1):370-81.
25. Instituto Nacional de Câncer - INCA [homepage on the Internet]. Brasília: Ministério da Saúde. [cited 2007 Sep 12]. Atlas de Mortalidade por Câncer no Brasil 1979-1999. Available from: http://www.inca.gov.br/atlas.